HIV vaccine in Kenya
Kenya is one of the leading African countries that have started AIDS vaccine trials. The Kenyan AIDS Vaccine Initiative (KAVI) was initiated in 1998 and began HIV-1 vaccine trials in 2001. All of the vaccines that were tested have been specifically designed to be used in Kenya but have also been tested in UK. Phase One testing in humans has been proven to be safe and, says Dr Omu Anzala of KAVI, second phase vaccine trials will kick off soon. These will take approximately two years and will test the body’s immune response to the vaccine. The trials will include volunteers from Nairobi and London. Thandeka Teyise of Health-e News Service spoke to Dr Anzala and asked him to explain KAVI’S second phase of the vaccine trials.
This report is in isiXhosa and English.
To listen click here.
Author
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
You must include all of the links from our story, including our newsletter sign up link.
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
HIV vaccine in Kenya
by Thandeka Teyise, Health-e News
June 6, 2003